Literature DB >> 3913287

Structure and biological activity of heparin.

B Casu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913287     DOI: 10.1016/s0065-2318(08)60067-0

Source DB:  PubMed          Journal:  Adv Carbohydr Chem Biochem        ISSN: 0065-2318            Impact factor:   12.200


× No keyword cloud information.
  49 in total

1.  Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity.

Authors:  L C Chang; J F Liang; H F Lee; L M Lee; V C Yang
Journal:  AAPS PharmSci       Date:  2001

2.  Conformation of heparin studied with macromolecular hydrodynamic methods and X-ray scattering.

Authors:  Georges Pavlov; Stéphanie Finet; Karine Tatarenko; Evgueniya Korneeva; Christine Ebel
Journal:  Eur Biophys J       Date:  2003-07-03       Impact factor: 1.733

3.  Structural snapshots of heparin depolymerization by heparin lyase I.

Authors:  Young-Hyun Han; Marie-Line Garron; Hye-Yeon Kim; Wan-Seok Kim; Zhenqing Zhang; Kyeong-Seok Ryu; David Shaya; Zhongping Xiao; Chaejoon Cheong; Yeong Shik Kim; Robert J Linhardt; Young Ho Jeon; Miroslaw Cygler
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

Review 4.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

5.  Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.

Authors:  A J Rhomberg; S Ernst; R Sasisekharan; K Biemann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 6.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Nitric oxide degradation of heparin and heparan sulphate.

Authors:  R E Vilar; D Ghael; M Li; D D Bhagat; L M Arrigo; M K Cowman; H S Dweck; L Rosenfeld
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

8.  Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.

Authors:  Po-Hung Hsieh; Yongmei Xu; David A Keire; Jian Liu
Journal:  Glycobiology       Date:  2014-04-25       Impact factor: 4.313

9.  Glycosaminoglycans from earthworms (Eisenia andrei).

Authors:  A-Rang Im; Youmie Park; Joon-Soo Sim; Zhenqing Zhang; Zhenling Liu; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycoconj J       Date:  2009-12-16       Impact factor: 2.916

10.  Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans.

Authors:  Muchena J Kailemia; Lingyun Li; Yongmei Xu; Jian Liu; Robert J Linhardt; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2013-02-21       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.